817 resultados para Foster home care.


Relevância:

90.00% 90.00%

Publicador:

Resumo:

Cover title.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Subsequent issues of each vol. constitute revisions of the previous ones.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

"In the future, additional sections for the Home Services Program Manual will be mailed as they are completed."

Relevância:

90.00% 90.00%

Publicador:

Resumo:

At head of title: Annual joint report to the Governor and the Illinois General Assembly on Public Act 81-202.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Research conducted by Abt Associates.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

At head of title: Title 77: Public health, Chapter I: Department of Public Health, subchapter C: long-term care facilities.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Caption title.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Contains rules and regulations under the authority of the Nursing Home Care Act, that govern the licensure of long-term care facilities which provide sheltered care.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Derived from Nursing Home Care Act.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Authorized by the Nursing Home Care Reform Act of 1979.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Objective. Despite widespread adoption of home care services, few randomised trials have compared health outcomes in the hospital and at home. We report a prospective, randomised trial of home versus hospital therapy in adults receiving intravenous (IV) antibiotics. Our objective was to show that home care is a feasible alternative to hospitalisation over a broad range of infections, without compromise to quality of life (QOL) or clinical outcomes. Methods. Consenting adults requiring IV antibiotics were randomised to complete therapy at home or in hospital. Short Form 36 and Perceived Health Competence Scale (PHCS) were used for assessment of QOL. Statistical analysis used unpaired t-tests, Mann-Whitney tests and ANOVA. Results. One hundred and twenty-nine admissions were referred. Recruitment was hampered by patient preference for one therapy over another. 82 (62%) were included and randomised: 44 to home, 38 to hospital; the two groups had comparable characteristics. There were no differences in improvements in QOL and PHCS scores between the two groups after treatment. Treatment duration was median 11.5 days (range 3 - 57) and 11 days (range 4 - 126) for home and hospital groups, respectively. Home therapy costs, approximately, half that of hospital therapy. Time to readmission was longer after hospital therapy. Conclusion. Out study showed that home IV therapy is welt tolerated, is less costly, is not associated with any major disadvantage to QOL or clinical outcomes compared to hospital therapy, and is an appropriate treatment option for selected patients. (C) 2003 The British Infection Society. Published by Elsevier Ltd. All rights reserved.